51S Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Cynata Therapeutics Ltd

Watchlist Manager

Watchlist

Price: 0.0005 EUR Market Closed

Market Cap: €90.3k

	Cynata Therapeutics Ltd F:51S	AU
G	Glatfelter Corp F:GLN	US
	Omega Pacific Resources Inc F:Q0F	CA
S	Serra Energy Metals Corp CNSX:APPT	CA
S	Silver Bull Resources Inc OTC:SVBL	CA
T	Trinity Resources Inc OTC:TRRI	US
H	Hexagon Energy Materials Ltd SWB:F93	AU

Profitability Summary

Cynata Therapeutics Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-4 128%

Negative 3Y Average Operating Margin

-3 411%

Declining Operating Margin

-4 119% > -4 128%

Negative Net Margin

-4 131%

Negative 3Y Average Net Margin

-3 393%

Declining Net Margin

-4 046% > -4 131%

Negative Free Cash Flow Margin

-4 022%

Negative 3Y Average Free Cash Flow Margin

-3 188%

Free Cash Flow Margin is Increasing

-4 047% > -4 022%

Negative ROE

-113%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-654%

ROIC is Increasing

-1 103% > -738%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.